newsfilter
← Latest News
GlobeNewswire·

Immuneering to be Added to the Nasdaq Biotechnology Index (NBI)

NEW YORK, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (NASDAQ:IMRX), a late-stage clinical oncology company focused on keeping cancer patients alive and helping them thrive, today announced that it is